共 29 条
- [1] Expression of EGFR and HPV-associated p16 in head and neck cancer: correlation and influence on prognosis after radiotherapy in 1088 patients from the randomised DAHANCA 5, 6 & 7 trials EJC SUPPLEMENTS, 2009, 7 (02): : 470 - 470
- [2] A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression HEAD & NECK PATHOLOGY, 2022, 16 (04): : 1251 - 1256
- [3] A Case of HPV-Associated Oropharyngeal Squamous Cell Carcinoma with Block-Like, Partial Loss of p16 Expression Head and Neck Pathology, 2022, 16 : 1251 - 1256
- [4] HPV-associated p16-expression and response to radiobiological modifications of radiotherapy in head and neck cancer: results from the randomised DAHANCA trials EJC SUPPLEMENTS, 2009, 7 (03): : 11 - 11
- [8] Correlation of HPV16 infection and p16 expression with prognosis in patients with hypopharyngeal carcinoma INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 4978 - 4985
- [9] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful? Head and Neck Pathology, 2020, 14 : 966 - 973
- [10] Metastatic HPV-Associated Oropharyngeal Versus Primary Pulmonary Squamous Cell Carcinoma: is p16 Immunostain Useful? HEAD & NECK PATHOLOGY, 2020, 14 (04): : 966 - 973